JPRN-UMIN000053045
Recruiting
N/A
Prospective study of biomarkers and pharmacological characteristics for patients with metastatic lung tumors - Prospective study of biomarkers and pharmacological characteristics for patients with metastatic lung tumors
Conditionsmetastatic lung tumor
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- metastatic lung tumor
- Sponsor
- Keio University
- Enrollment
- 550
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who are deemed by the principal investigator or subinvestigator to be inappropriate to conduct this study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Prospective research of the biomarkers associated with adjuvant chemotherapy in patients with resectable biliary tract cancerBiliary tract cancerJPRN-UMIN000004613Department of Medical Oncology, University of Miyazaki Hospital50
Completed
N/A
Research for biomarkers to predict the effectiveness of zoledronic acid in metastatic bone tumorsPatients with bone metastases newly treated by zoledronic acidJPRN-UMIN000018556agoya University Graduate School and School of Medicine27
Completed
N/A
Research for biomarkers to predict the effectiveness of denosumab in metastatic bone tumorsPatients with bone metastases newly treated by denosumabJPRN-UMIN000019700agoya University Graduate School and School of Medicine40
Recruiting
N/A
Exploratory study of biomarkers for therapeutic efficacy and immune-related adverse events of immune checkpoint inhibitorsAll cancer types indicated for immune checkpoint inhibitorJPRN-UMIN000043798Kumamoto University400
Recruiting
N/A
An exploratory prospective study of the biomarkers of the immune-related adverse events (irAE) and the mechanisms of irAE in solid cancer patients treated with Pembrolizumab.solid cancerJPRN-UMIN000028474Department of Internal Medicine, Division of Medical Oncology, Showa University School of Medicine.30